FATE
Fate Therapeutics Inc
Price:  
3.90 
USD
Volume:  
1,342,019.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE WACC - Weighted Average Cost of Capital

The WACC of Fate Therapeutics Inc (FATE) is 6.5%.

The Cost of Equity of Fate Therapeutics Inc (FATE) is 9.35%.
The Cost of Debt of Fate Therapeutics Inc (FATE) is 5.00%.

Range Selected
Cost of equity 8.00% - 10.70% 9.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 7.2% 6.5%
WACC

FATE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.89 1.04
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.00% 10.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 7.2%
Selected WACC 6.5%